Senile plaques are abnormal clusters of protein fragments known as beta-amyloid that accumulate between nerve cells in the brains of individuals with Alzheimer's disease. These plaques are one of the hallmark features of the disease and are believed to disrupt communication between neurons, contributing to cognitive decline and memory loss. Over time, the accumulation of these plaques can lead to inflammation and damage to nearby cells, further impairing brain function.
Researchers believe that understanding how and why these plaques form is crucial to developing effective treatments for Alzheimer's disease and related dementias. Strategies to reduce plaque formation or enhance the brain's ability to clear these proteins are areas of active investigation in the quest to slow or halt the progression of Alzheimer's disease. Thus, senile plaques not only serve as a diagnostic marker but also represent a focal point for therapeutic interventions aimed at combating this devastating neurodegenerative disorder.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China